Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin
Open Access
- 29 May 2002
- journal article
- clinical trial
- Published by Wiley in American Journal of Hematology
- Vol. 70 (2) , 92-99
- https://doi.org/10.1002/ajh.10076
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Idiopathic myelofibrosis: pathogenesis, natural history and managementBlood Reviews, 1997
- Recombinant human erythropoietin in the treatment of cancer‐related anaemiaEuropean Journal of Haematology, 1997
- Combination Therapy with Recombinant Human Erythropoietin, Interferon-α-2b and Granulocyte- Macrophage Colony-Stimulating Factor in Idiopathic MyelofibrosisActa Haematologica, 1996
- Recombinant human erythropoietin for the treatment of anemia in myelofibrosis with myeloid metaplasiaAmerican Journal of Hematology, 1995
- RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIABritish Journal of Haematology, 1994
- Recombinant Human Erythropoietin in Patients with Myelodysplastic Syndrome and MyelofibrosisActa Haematologica, 1993
- Resolution of transfusion dependence by recombinant human erythropoietin (rHuEPO) in acquired pure red cell aplasia (PRCA) associated with myeloid metaplasiaBritish Journal of Haematology, 1993
- Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders [letter; comment]Blood, 1992
- Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments]Blood, 1992
- Progress toward human gene therapyBlood, 1990